Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ATCC RPMI 2650; Nasal Septum Carcinoma; Human (Homo sapiens)
Supplier: ATCC CCL30
RPMI 2650 is a cell line exhibiting epithelial morphology from the nasal septum of a 52-year-old, male patient with squamous cell carcinoma. This cell line was deposited by GE Moore and can be used in cancer research, and toxicology.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?